By Saleh Farouq Gagarawa, anipr
Tuberculosis does not begin in hospitals. It begins quietly, often as a cough that lingers longer than expected. A symptom dismissed. A delay justified. A moment lost. And in that delay lies a cost far greater than most systems are designed to measure.
In Nigeria, where Tuberculosis remains a major public health concern, the conversation has largely focused on detection, treatment, and funding gaps. But there is a deeper, often overlooked dimension to the crisis. The cost of delayed diagnosis, not only to the individual, but to households, communities, and the nation as a whole.
At the household level, delay is rarely just a health issue. It quickly becomes an economic shock.
When symptoms persist without diagnosis, individuals often continue daily activities while unwell, gradually losing strength and productivity. For many Nigerians, especially those in informal employment, income is directly tied to daily physical output. A trader who cannot open their shop, a farmer who cannot tend to their land, a laborer who cannot work, each day without diagnosis is a day without income.
What follows is a predictable but devastating cycle. Savings are depleted. Informal care is sought, often through multiple providers, leading to repeated out of pocket spending without resolution. Families begin to reallocate resources, prioritizing immediate survival over long term stability. Children may be withdrawn from school. Nutrition declines. The illness, initially manageable, becomes prolonged and more severe.
This is not just a health burden. It is economic erosion.
At the same time, the risk of transmission continues. Tuberculosis spreads through the air, and each undiagnosed individual may unknowingly infect others within their household or community. What began as one delayed case can quietly multiply into several. The cost is no longer contained within one family. It expands outward.
At the national level, the implications are even more profound.
Delayed diagnosis increases the overall burden on the health system. Patients who present late often require more complex care, longer treatment durations, and in some cases, management of complications that could have been prevented. This places additional strain on already limited resources.
Beyond the health system, the productivity loss is significant. A workforce affected by undiagnosed and untreated TB is a workforce operating below capacity. When large numbers of people are intermittently or permanently unable to contribute economically, the impact is reflected in reduced productivity, increased dependency, and slower economic growth.
There is also a hidden cost in data.
When cases are not diagnosed early, they are not captured in real time. This creates gaps between the actual burden of disease and what is reported. Planning becomes less precise. Resource allocation becomes less efficient. The system is forced to respond to an incomplete picture.
In this context, delayed diagnosis is not just a clinical issue. It is a structural one.
Across multiple states including Borno State, Yobe State, Gombe State, and Plateau State, field experiences continue to show that the point of delay often occurs before individuals reach formal health facilities. Many first seek care in community settings, through informal providers, or delay care entirely due to stigma, cost concerns, or lack of awareness.
This is where the most critical interventions must occur.
The Leprosy and Tuberculosis Relief Nigeria, through its community focused programming, has been working to shorten this delay by strengthening the pathways between symptom onset and diagnosis. Through mentorship of community level providers, supportive supervision, and improved referral systems, the time between suspicion and testing is gradually being reduced.
Data harmonization and on-site validation efforts are also helping ensure that once cases are identified, they are accurately recorded and linked to care. These are not abstract interventions. They directly influence how quickly a person moves from illness to diagnosis, and from diagnosis to treatment. The lesson is clear.
Every day of delay has a cost, a cost to the patient, a cost to the family, a cost to the system, a cost to the nation.
But the inverse is also true. Every day saved has value.
Early diagnosis protects household income. It reduces transmission. It lowers treatment complexity. It improves outcomes. It strengthens data. It saves resources.
If Nigeria is to meaningfully reduce the burden of tuberculosis, then the focus must shift from treating cases to finding them early. Not as an abstract goal, but as an economic and social priority.
Because in the end, the question is not whether we can afford to invest in early diagnosis.
It is whether we can afford not to.
